[{"from": "human", "value": "What can you tell me about this molecule? [C][=C][C][=C][Branch2][Branch1][P][C][=Branch1][Ring2][=C][Ring1][=Branch1][C][N][C][=Branch2][Ring2][=C][=C][C][=Branch1][Ring2][=N][Ring1][Branch1][C][=N][C][=C][Branch2][Ring1][#C][C][=Branch1][Ring2][=N][Ring1][=Branch1][N][C][C][Branch1][=Branch2][C][Branch1][C][F][Branch1][C][F][F][Branch1][=Branch2][C][Branch1][C][F][Branch1][C][F][F][O][F][C][=N][O][C][=C][Ring1][Branch1][F]"}, {"from": "gpt", "value": "The molecule is a member of the class of pyrazoles that is 5-fluoro-2-(1H-pyrazol-3-yl)pyrimidine which is substituted by a 2-fluorobenzyl group at position 1, 1,2-oxazol-3-yl group at position 5, and by a [3,3,3-trifluoro-2-hydroxy-2-(trifluoromethyl)propyl]nitrilo group at position 4. It is a soluble guanylate cyclase stimulator under clinical development for the treatment of heart failure with preserved ejection fraction. It has a role as a soluble guanylate cyclase activator, an anti-inflammatory agent, a vasodilator agent and an antihypertensive agent. It is a member of isoxazoles, a member of pyrazoles, an organofluorine compound, an aminopyrimidine, a tertiary alcohol, a secondary amino compound and a member of monofluorobenzenes."}]